Clinical Trial Update: Efficacy of Levodopa/Benserazide Dispersible Tablet on Response Fluctuations in PD Patients With Delayed ON [Phase 4]

View source ↗

Summary

Phase 4 trial updating the efficacy of Levodopa/Benserazide Dispersible Tablet on response fluctuations in Parkinson disease patients with delayed ON.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Levodopa/Benserazide Dispersible Tablet (levodopa benserazide dispersible tablet)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Parkinson Disease | Phase 4 | Status: COMPLETED